Back

Interactive discussion and Q&A

29 August 2025 (15:50 - 16:00)
Organised by: Logo
Congress Presentation Part of: The clinical continuum of atrial fibrillation: balancing risks to optimise outcomes Oral Anticoagulant Drugs Open Access ESC Congress 2025 European Society of Cardiology

About the speakers

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Photo
Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)

Photo
Professor Derek Connolly

City Hospital, Birmingham (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor G. Lip (Liverpool, GB)
Slides
Presentation thumbnail
Balancing atrial fibrillation burden with stroke risk and the need for anticoagulation
Doctor E. Svennberg (Stockholm, SE)
Slides
Presentation thumbnail
Updates on the latest real-world evidence on the use of direct oral anticoagulants (DOAC) in non-valvular atrial fibrillation (NVAF)
Professor G. Lip (Liverpool, GB)
Slides
Presentation thumbnail
From data to decision-making: applying evidence and guidelines to clinical practice
Professor D. Connolly (Birmingham, GB)
Slides

Access the full session

Session thumbnail
The clinical continuum of atrial fibrillation: balancing risks to optimise outcomes
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 15:50 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
Update on antiarrhythmic therapy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources